X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (364) 364
index medicus (304) 304
male (291) 291
female (277) 277
adult (276) 276
infectious diseases (276) 276
hiv (223) 223
middle aged (217) 217
hiv infections - drug therapy (201) 201
immunology (160) 160
cohort studies (140) 140
antiretroviral therapy (134) 134
virology (110) 110
hiv infection (100) 100
hiv infections - virology (98) 98
switzerland (90) 90
microbiology (89) 89
risk factors (83) 83
hiv infections - complications (82) 82
human immunodeficiency virus--hiv (82) 82
aids (81) 81
infection (81) 81
switzerland - epidemiology (80) 80
viral load (80) 80
anti-hiv agents - therapeutic use (77) 77
cd4 lymphocyte count (76) 76
prospective studies (69) 69
aged (68) 68
antiviral agents (65) 65
aids/hiv (63) 63
analysis (63) 63
pharmacology & pharmacy (63) 63
research (62) 62
drug therapy (61) 61
mortality (61) 61
hiv infections - epidemiology (60) 60
610 medicine & health (58) 58
antiretroviral therapy, highly active (58) 58
health aspects (56) 56
prevalence (56) 56
therapy (56) 56
treatment outcome (56) 56
highly active antiretroviral therapy (55) 55
hiv infections - immunology (55) 55
young adult (51) 51
care and treatment (50) 50
infections (50) 50
active antiretroviral therapy (47) 47
antiretroviral drugs (47) 47
hiv-1 - genetics (47) 47
adolescent (46) 46
human-immunodeficiency-virus (46) 46
risk (46) 46
hiv patients (45) 45
cohort (44) 44
virus diseases (44) 44
epidemiology (42) 42
anti-hiv agents - administration & dosage (41) 41
clinic for infectious diseases (40) 40
genotype (40) 40
infected patients (40) 40
patients (40) 40
hiv-1 (39) 39
hiv/aids (37) 37
hiv-1 - drug effects (35) 35
individuals (34) 34
hiv infections - transmission (33) 33
rna, viral - blood (32) 32
transmission (32) 32
acquired immune deficiency syndrome--aids (31) 31
anti-retroviral agents - therapeutic use (31) 31
disease progression (31) 31
incidence (31) 31
medicine (31) 31
anti-hiv agents - adverse effects (30) 30
human immunodeficiency virus (30) 30
usage (30) 30
antiretroviral agents (29) 29
antiretrovirals (29) 29
rna (29) 29
medicine, general & internal (28) 28
tenofovir (28) 28
abridged index medicus (27) 27
drug therapy, combination (27) 27
hiv infections - mortality (27) 27
impact (27) 27
prognosis (27) 27
research article (27) 27
diagnosis (26) 26
dosage and administration (26) 26
hiv-1 - isolation & purification (26) 26
multidisciplinary sciences (26) 26
patient outcomes (26) 26
antiretroviral therapy, highly active - methods (25) 25
drug resistance (25) 25
medical research (25) 25
protease inhibitors (25) 25
time factors (25) 25
viruses (25) 25
genetic aspects (24) 24
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 1, pp. 43 - 52
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2014, Volume 59, Issue 2, pp. 287 - 297
Journal Article
AIDS (London, England), ISSN 0269-9370, 2010, Volume 24, Issue 11, pp. 1667 - 1678
Journal Article
Journal Article
Journal Article
by Emery, Sean and Neuhaus, Jacqueline A and Phillips, Andrew N and Babiker, Abdel and Cohen, Calvin J and Gatell, Jose M and Girard, Pierre-Marie and Grund, Birgit and Law, Matthew and Losso, Marcelo H and Palfreeman, Adrian and Wood, Robin and Gordin, F and Finley, E and Dietz, D and Chesson, C and Vjecha, M and Standridge, B and Schmetter, B and Grue, L and Willoughby, M and Demers, A and Lundgren, J.D and Phillips, A and Dragsted, U.B and Jensen, K.B and Fau, A and Borup, L and Pearson, M and Jansson, P.O and Jensen, B.G and Benfield, T.L and Darbyshire, J.H and Babiker, A.G and Palfreeman, A.J and Fleck, S.L and Collaco-Moraes, Y and Cordwell, B and Dodds, W and van Hooff, F and Wyzydrag, L and Cooper, D.A and Drummond, F.M and Connor, S.A and Satchell, C.S and Gunn, S and Oka, S and Delfino, M.A and Merlin, K and McGinley, C and Neaton, J.D and Bartsch, G and Duchene, A and George, M and Harri-Harrison, M and Hogan, C and Krum, E and Larson, G and Miller, C and Nelson, R and Neuhaus, J and Roediger, M.P and Schultz, T and Thackeray, L and Prineas, R and Campbell, C and Perez, G and Lifson, A and Duprez, D and Hoy, J and Lahart, C and Perlman, D and Price, R and Rhame, F and Sampson, J and Worley, J and Rein, Board M and Dersimonian, R and Brody, B.A and Daar, E.S and Dubler, N.N and Fleming, T.R and Freeman, D.J and Kahn, J.P and Kim, K.M and Medoff, G and Modlin, J.F and Moellering, R and Murray, B.E and Pick, B and Robb, M.L and Scharfstein, D.O and Sugarman, J and Tsiatis, A and Tuazon, C and Zoloth, L and Klingman, K and Lehrman, S and Lazovski, J and Belloso, W.H and ... and SMART Study Grp and Strategies for Management of Antiretroviral Therapy (SMART) Study Group and The Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2008, Volume 197, Issue 8, pp. 1133 - 1144
Journal Article
AIDS (London, England), ISSN 0269-9370, 2013, Volume 27, Issue 5, pp. 803 - 813
To estimate the incidence of and risk factors for modifications to first antiretroviral therapy (ART) regimen, treatment interruption and death. A total of 21... 
HIV/AIDS | MORTALITY | FRENCH-HOSPITAL-DATABASE | INFECTIOUS DISEASES | competing-risk method | VIROLOGICAL TREATMENT FAILURE | survival | AIDS | COMPETING RISKS | IMMUNOLOGY | DISCONTINUATION | switch | antiretroviral | VIROLOGY | RECOMMENDATIONS | ACTIVE ANTIRETROVIRAL THERAPY | interruption | INFECTED PATIENTS | COHORT | HIV-1 | United States - epidemiology | Lamivudine - administration & dosage | Humans | HIV Seropositivity - mortality | HIV Seropositivity - drug therapy | Nevirapine - adverse effects | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Adenine - adverse effects | Time Factors | Deoxycytidine - adverse effects | HIV Infections - mortality | Dideoxynucleosides - adverse effects | Antiretroviral Therapy, Highly Active - methods | Dideoxynucleosides - administration & dosage | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Risk Factors | Organophosphonates - adverse effects | Europe - epidemiology | Benzoxazines - adverse effects | HIV Protease Inhibitors - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Lopinavir - administration & dosage | HIV Infections - drug therapy | Nevirapine - administration & dosage | Deoxycytidine - analogs & derivatives | Drug Combinations | Lopinavir - adverse effects | Cohort Studies
Journal Article
Plos Medicine, ISSN 1549-1676, 2015, Volume 12, Issue 3, pp. e1001809 - e1001809
Journal Article